PLUS1
6.26
0.00 (0.0%)
0.00 (0.0%)
Upgrade to Real-Time
Premarket
| Volume | 0 |
|
|||||
| News | (1) | ||||||
| Day High | Low High |
||||||
| Day Low | |||||||
Best deals to access real time data! |
|
Ultimate Trader (Monthly)
Monthly Subscription
for only
|
|
Small Cap Basic
Monthly Subscription
for only
|
|
Big Cap Pro
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| F star Therapeutics Inc | FSTX | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
 |
|
|---|---|---|---|---|
| 0.00 | 0.0% | 6.26 | 04:00:00 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 6.26 |
| Trades | Volume | Avg Volume | 52 Week Range |
|---|---|---|---|
| 0 | 0 | - | 2.07 - 8.41 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| - | 0 | $ 6.26 | USD |
Period:
Draw Mode:
F star Therapeutics Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 135.12M | 21.58M | 21.35M | $ 21.17M | $ -19.38M | -2.04 | -4.10 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | - | - | 2.40% |
F star Therapeutics News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical FSTX Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 6.30 | 6.34 | 6.13 | 6.27 | 373,113 | -0.04 | -0.63% |
| 1 Month | 4.06 | 6.66 | 3.044 | 5.98 | 774,759 | 2.20 | 54.19% |
| 3 Months | 3.33 | 6.66 | 2.07 | 5.12 | 343,639 | 2.93 | 87.99% |
| 6 Months | 4.74 | 6.66 | 2.07 | 4.68 | 223,796 | 1.52 | 32.07% |
| 1 Year | 7.71 | 8.41 | 2.07 | 5.46 | 211,508 | -1.45 | -18.81% |
| 3 Years | 3.90 | 15.50 | 2.07 | 6.42 | 186,429 | 2.36 | 60.51% |
| 5 Years | 3.90 | 15.50 | 2.07 | 6.42 | 186,429 | 2.36 | 60.51% |
F star Therapeutics Description
| F-star Therapeutics Inc is a clinical-stage biopharmaceutical company developing tetravalent bispecific antibodies for a paradigm-shift in cancer therapy. By developing medicines that seek to block tumor immune evasion, the company's goal is to offer patients greater and more durable benefits than immuno-oncology treatments. |
